Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.

Abstract: A control circuit applied to a power adapter includes a voltage conversion unit and a switch control unit. The voltage conversion unit is configured to: receive a first direct current voltage, and generate a second direct current voltage based on the first direct current voltage, where when the first direct current voltage is lower than a working voltage of the switch control unit, the voltage conversion unit is configured to boost the first direct current voltage, to obtain the second direct current voltage. The switch control unit is configured to: receive the second direct current voltage from the voltage conversion unit, and use the second direct current voltage as a power supply voltage of the switch control unit.

Abstract: A semiconductor package comprises a controlled voltage domain (CVD) and a master voltage domain (MVD). The MVD comprises an error-tolerance control (ETC) circuit. A basic execution block in the CVD generates a basic output value, based on at least two input values. A test execution block in the CVD generates a test digital root, based on digital roots of the input values. A digital root comparator in the CVD determines whether a digital root of the basic output value matches the test digital root. An error reporter in the CVD sends an error report to the ETC circuit in response to a determination that the digital roots do not match. The ETC may automatically adjust at least one power characteristic of the CVD, based on the error report. Other embodiments are described and claimed.

Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.

Abstract: An automatic recognition and classification method for electrocardiogram heartbeat based on artificial intelligence, comprising: processing a received original electrocardiogram digital signal to obtain heartbeat time sequence data and lead heartbeat data; cutting the lead heartbeat data according to the heartbeat time sequence data to generate lead heartbeat analysis data; performing data combination on the lead heartbeat analysis data to obtain a one-dimensional heartbeat analysis array; performing data dimension amplification and conversion according to the one-dimensional heartbeat analysis array to obtain four-dimensional tensor data; and inputting the four-dimensional tensor data to a trained LepuEcgCatNet heartbeat classification model, to obtain heartbeat classification information.

Abstract: Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.

Abstract: An artificial intelligence-based interference recognition method for an electrocardiogram, comprising: cutting and sampling heart beat data of a first data amount, and inputting the heart beat data to be recognized that is obtained by cutting and sampling into an interference recognition binary classification model for interference recognition; in a sequence of the heart beat data, performing signal anomaly determination on a heart beat data segment where an inter-beat interval is greater than or equal to a preset interval determination threshold value, so as to determine whether the heart beat data segment is an abnormal signal; if the heart beat data segment is not an abnormal signal, determining a starting data point and an ending data point of sliding sampling in the heart beat data segment according to a set time with a preset time width, and performing sliding sampling on the data segment from the starting data point until the ending data point so as to obtain multiple sampling data segments; and using

Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.

Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.

Abstract: The wireless sensor network can including a plurality of anchor sensors each including a signal receiver, a processing module, and a transmitter. The signal receiver can be configured to detect a received signal. The received signal can include noise and further can include a transmitted signal from the node when the node is transmitting the transmitted signal. The node can be located at an exact location that is unknown to each of the plurality of anchor sensors. The exact location can be in a region that is known to each of the plurality of anchor sensors. The transmitted signal can be wirelessly transmitted from the node when the node is transmitting the transmitted signal. The wireless sensor network also can include a fusion center. The processing module of each anchor sensor of the plurality of anchor sensors can performs acts. The acts can include determining a probability of whether the node is present at each of a plurality of grid points of the region.

Abstract: A quantum dot lighting device includes a quantum-dot-lighting layer and two main structural layers being arranged at two sides of the quantum-dot-lighting layer along a vertical direction. The quantum-dot-lighting layer includes a red lighting unit, a green lighting unit, and a red lighting unit. The red lighting unit includes red quantum dots, the green lighting unit includes green quantum dots, and the blue lighting unit includes blue quantum dots. A number of the blue quantum dots is larger than the number of the green quantum dots, and the number of the green quantum dots is larger than the number of the red quantum dots. With the configuration, the material of the quantum dots may be reduced, and the pureness of the white light beams may be enhanced.

Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.

Abstract: A quantum dot lighting device includes a quantum-dot-lighting layer and two main structural layers being arranged at two sides of the quantum-dot-lighting layer along a vertical direction. The quantum-dot-lighting layer includes a red lighting unit, a green lighting unit, and a red lighting unit. The red lighting unit includes red quantum dots, the green lighting unit includes green quantum dots, and the blue lighting unit includes blue quantum dots. A number of the blue quantum dots is larger than the number of the green quantum dots, and the number of the green quantum dots is larger than the number of the red quantum dots.

Abstract: Some embodiments include a wireless sensor network system. Other embodiments of related systems and methods are also disclosed.

Abstract: A cursor control method and cursor control device of a smart TV, wherein when a character inputting box in a character inputting interface is in a non-editing state, the method includes the following steps: receiving and resolving a control signal from a remote control; triggering the character inputting box into an editable state if the control signal instructs to move the cursor into the character inputting box; judging whether a string exists in the character inputting box; if the judgement result is yes, judging a target position in the string where an input error may exist; and positioning the cursor at the target position in the string. The cursor control method and cursor control device of a smart TV in the present disclosure can make modification of strings existed in the character inputting box is more convenient, thereby improving modification efficiency and saving input operation cost for users.

Abstract: The invention relates to an isolated interleukin-17 (IL-17)-binding agent which comprises an immunoglobulin heavy chain polypeptide comprising SEQ ID NO: 1, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 78, or SEQ ID NO: 79, and an immunoglobulin light chain polypeptide comprising SEQ ID NO: 23, except that one or more specific of residues of SEQ ID NO: 1 and SEQ ID NO: 23 are replaced with a different residue. The invention also provides vectors, compositions, and methods of using the IL-17-binding agent to treat an IL-17-mediated disease.

Abstract: To achieve space correlation of pixel decomposition results and reduce noise problem caused by isolation, there is provided a decomposition apparatus and method for refining composition of mixed pixels in remote sensing images, including: a preprocessing step for temporarily determining the provability value of the composition ratio of the different land cover types of each pixel in the image, based on a received remote sensing image and spectral information, to obtain first material composition information; and a neighborhood correlation calculation step for analyzing the correlation between a main pixel and the neighboring areas by using the first material composition information of each of the pixels present in the neighboring areas within a predetermined range in which the pixels are adjacent to each other, and optimizing the first material composition information of the main pixel by the result of the correlation analysis, to obtain second material composition information.